Objective: To compare the effectiveness and cost-effectiveness of three methods of inviting women with a long history of non-attendance to undergo cervical screening. Methods: Randomized controlled trial and cost-effectiveness analysis. In all, 1140 women were identified from routine NHS screening records as having no smear for at least 15 years and randomly allocated to receive a telephone call from a nurse, a letter from a well-known celebrity (Claire Rayner) or letter from the local NHS Cervical Screening Commissioner. Uptake of screening was measured using routine data and attributed to interventions if occurring within three months. Uptake was compared with a control group. Costs of carrying out the interventions were noted from the perspective of the NHS and cost-effectiveness, as cost per additional attender, calculated. Results: Uptake following all interventions was low: telephone call (1.4, 95% confidence interval [CI] 0.38-3.6%); celebrity letter (1.8, 95% CI 0.57-4.0%); commissioner letter (4.6, 95% CI 2.5-7.7%); control group (1.8, 95% CI 0.57-4.0%). There were no significant differences between groups. Telephone intervention was not possible in a quarter of women whose numbers were unlisted. Telephone intervention was the most expensive and least effective of the interventions. The commissioner letter yielded an additional attender within three months at an incremental cost of £23.21 compared with taking no action. Conclusions: Neither a telephone call from a nurse nor a letter from a celebrity to encourage attendance for cervical screening were effective or cost-effective in women with a prolonged history of non-participation in the screening programme. A letter from the local cervical screening programme commissioner resulted in a small, non-significant increase in uptake. The low cost and ease of implementation of this intervention supports further research into its use in routine practice.
INTRODUCTION
Women with a prolonged history of non-screening for cervical cancer are at an increased relative risk of developing invasive cancer. 1 Although over 80% of eligible women are screened five yearly, there remain a large number of women who have not been screened for more than 15 years. In Devon (population approximately 1 million), this group amounts to over 8000 women. Standard call and recall procedures include personalized letters from general practitioners (GPs) sent at regular intervals (every 54 months), so women in this group have not attended for screening despite at least two such interventions.
A recent systematic review of interventions to encourage attendance for screening showed that invitation letters and telephone calls are effective in increasing screening uptake compared to no systematic invitation. 2 Five studies comparing different methods of invitation were included, with equivocal results. All were carried out in the USA. Telephone calls were shown to be more cost-effective than letters in one study. 3 There have been no studies of different methods of invitation in women who have a long history of non-attendance for screening. Currently, routine practice in the UK cervical cancer screening programmes is for local health authorities and/or general practitioners to write to eligible women, 'inviting' them (in a friendly but authoritative way) to attend for screening.
In this study we aimed to evaluate, in a randomized controlled trial, the effectiveness and cost-effectiveness of three different approaches to inviting women who had not attended for screening for more than 15 years. The approaches were: telephone call from a nurse; letter from the local health authority screening commissioner (a consultant in public health medicine); and letter from a celebrity encouraging attendance. This third intervention was based on a social marketing approach. 4 This is more consumer orientated and, in this study, a well-known celebrity (Claire Rayner) agreed to act as 'social marketer' -using the impact of her success and influence (creativity, intellect, etc.) on other people's lives to 'market' the idea being proposed -in this case, attending for screening.
METHODS
The study was approved by the three Local Research Ethics Committees covering the county of Devon.
All women in the appropriate age range (39-64 years) who were considered eligible for screening but did not have a screening history for the previous 15 years (n ¼ 8186) were identified from records held by the Devon Patient and Practitioners Services Agency (PPSA) database. These women formed the population from which the sample was drawn.
We considered a difference in screening uptake between the groups of at least 10% to be clinically worthwhile. Sample size calculation was carried out using Epi-Info 2000 (CDC, USA). 5 Based on an assumption of 10% uptake in the group receiving a letter from the Health Authority, and requiring 80% power and 95% precision to detect a clinically significant difference between groups, 219 participants were required in each group, including a control group who received no intervention. To allow for subsequent exclusions by GPs, we inflated sample size by 30%, giving a final requirement of 1140 participants.
The sample was drawn randomly from the sampling frame using Microsoft Excel. Allocation to the three intervention groups was carried out at random, independently of the research team and without knowledge of the identity of women in the sample, by the Exeter and North Devon Research and Development Support Unit, again using Microsoft Excel. The control group was selected at random from the original sampling frame at the analysis stage. The general practitioners of women in the intervention groups were contacted to check eligibility for inclusion (i.e. were not recently deceased, were currently resident in Devon, had not undergone hysterectomy and did not have a severe learning disability).
The interventions were carried out during a three-week period in June 2001 (see Figure 1 ).
The three interventions were the following:
(1) A telephone call from an experienced research nurse using a prepared script. A maximum of three attempts (on consecutive days) to make contact was set; (2) A letter from the Health Authority District Cervical Screening Commissioner (a public health doctor) on behalf of the National Cervical Screening Programme; (3) A letter from the celebrity Claire Rayner (Chair of the Patients Association and a well-known journalist and broadcaster); (4) Control: an equally sized group who received no intervention was selected from the sampling frame. GPs for this group were not contacted prior to the intervention, so no exclusions from this group were made.
The outcome measure was attendance for cervical screening within three months (90 days) of the intervention as recorded on the PPSA register. To allow for delay in the completion of records on this database following attendance for screening, the register was examined six months after the intervention.
Results were analysed on an intention-to-treat basis using w 2 test with Yates correction. Baseline characteristics were compared across the groups using w 2 , ANOVA and Kruskal-Wallis tests as appropriate. Socioeconomic status was measured ecologically using the Index of Multiple Deprivation (IMD2000) score for the ward of residence. 6 This is based on income, employment, health deprivation and disability, education, skills and training, housing and geographical access to services. Analyses were carried out using STATA version 8.0 (StataCorp LP, College Station, TX, USA). 7 Intervention costs were estimated by recording resource use prospectively and estimating the resource costs at 2001 prices. Costs of staff time, telephone calls and letters (paper, photocopying and postage) were included. In all, 2 h of screening manager time (£20) was required to set up the download of eligible women from the PPSA database. We assumed that 2 h of registered practice nurse time (£25) would be required to check the eligibility for intervention. The costs of obtaining support from the celebrity and drafting the celebrity and screening commissioner letters were not included. The perspective of the cost-effectiveness analysis was the NHS. Cost-effectiveness was calculated as incremental cost per additional screening attender (i.e. the costs and benefits accruing to individuals as a consequence of screening were not considered). Costs for the control group were considered to be zero since the objective was to identify the incremental costs associated with the addition of phone or letter interventions. Discounting was unnecessary as the time horizon for the study was less than one year.
RESULTS
The study identified 8186 cervical screening records of women aged 39-64 years living in Devon who had never been screened or who had not been screened in the past 15 years.
Baseline characteristics for the study sample (n ¼ 1140) were not significantly different between the intervention and control groups (see Table 1 ).
Around a fifth of participants in the intervention groups were excluded by GPs, for the reasons shown in Table 2 . Neither the total number of exclusions nor the reasons for exclusion were significantly different between groups, as tested using ANOVA and w 2 tests.
Within the telephone intervention group, 109 (49%) of the 222 attempted calls were successfully completed. In 25 (11.3%) unsuccessful calls no phone number was available, in 56 (25.2%) the number was unlisted and in one case the woman was out of the area. In 31 (13.9%) cases there was no reply after three calls or the woman had moved address. Six (3.2%) letters from the screening commissioner and seven (3.2%) letters from the celebrity were returned by the Post Office.
Logistic regression analysis showed that baseline factors (age, whether previously screened, number of previous smears and socioeconomic status) and the reason for exclusion by GPs (where relevant) were not associated with outcome.
Uptake of screening within three months of the intervention is shown in Table 3 . Overall, 27 women (2.4, 95% confidence interval [CI] 1.6-3.4%) had a cervical smear within three months of the intervention. Uptake in the control, telephone and celebrity letter groups was less than 2%.
Following the screening commissioner letter, 13 (4.6%) women were tested. This was not significantly more than the control or celebrity letter groups (w 2 ¼ 2.81, 2 df; P ¼ 0.09) or the telephone call group (w 2 ¼ 3.88, 2 df; P ¼ 0.055). Table 4 . The telephone intervention was the most expensive, both in absolute terms and per attender.
Table1 Baseline characteristics of intervention groups
In terms of cost-effectiveness, the telephone call was more costly and less effective than the commissioner letter and the control. The celebrity letter cost the same but was less effective than the commissioner letter. Compared with the control group, the commissioner letter was more expensive (£186) but resulted in eight more attendances, giving an incremental cost-effectiveness of £23.21 per additional attender.
DISCUSSION
The letter from the public health doctor as cervical screening commissioner was more influential in persuading women who had not been screened in the previous 15 years to have a cervical smear than either a telephone call, a letter from a celebrity or taking no action, although this difference was not statistically significant.
This study of simple methods to reduce health inequalities in screening uptake by increasing screening attendance in a group at high risk of cervical cancer demonstrates the feasibility of using routine data systems for measuring the simple outcome of attendance for screening. However, there are some methodological limitations. Attendance rate in the ensuing three months following the intervention was considered to be close enough to the intervention to reduce any secular trends, cohort effects or confounding, and yet to be attributable to the intervention. This assumption is untested. Although the difference between commissioner letter and control groups was not significant, power was low. Given the observed responses, the power of the study in this comparison was only around 50%.
A telephone intervention, although shown to be costeffective in a study from the USA, 8 was in our experience the most expensive and least effective intervention. We were unable to contact a quarter of the allocated number of women from this group in order to actually administer the intervention. Additionally, uptake among women who were contacted was still low at only 3.6%. It was not possible to identify the number of women who read the letters and so a 'treatment completer' analysis of alternative interventions was not possible.
Many women asked questions of a clinical nature during the telephone call, confirming the decision to use a health professional with experience of cervical screening in this intervention. This necessarily increased the cost of intervention but did not apparently result in an important increase in uptake compared with controls or the commissioner letter.
Social marketing, for health purposes, did not appear to have much impact on influencing womens' decisions to have a smear done. More qualitative work on the choice of social marketer and the nature of any influence would be valuable but were beyond the resources available. Using a social marketing approach, including use of a range of media, may be valuable in enhancing screening uptake, although we are aware of little UK research into this approach. The influence of the media on demand for screening was demonstrated by increased demand after the depiction of a case of cervical cancer in the television programme 'Coronation Street' during 2001. 9 However, most of the women who came forward for smears at that time were not overdue for a regular screening examination, suggesting the need for careful targeting in the use of broadcast media or social marketing as an approach to enhancing appropriate screening activity.
Although the difference between commissioner letter and control groups was not significant, and uncertainty must therefore remain over the value of this approach, the costeffectiveness analysis suggests that it could be a worthwhile intervention. Local arrangements for running the cervical screening programme use a high degree of automation in generating recall letters. Establishing an additional step, in which a personalized letter is sent to women with a long history of non-attendance, requires only limited resources and yields additional attenders at a cost of only £23.21 each. Furthermore, the average cost of the intervention will be lower than shown in this study, as not all costs vary with the size of the population approached (e.g. specifying PPSA download).
Even after such a long period of non-attendance for a cervical smear, there are people who respond to encouragement to attend for a smear. 10 Simple interventions from others in positions of social or professional influence (e.g. leaders of primary care organizations or GPs) may be worth testing further, particularly since the costs of intervention and associated evaluation are relatively low. Alongside this, we believe that further qualitative research would be valuable to explore the attitudes of women towards screening, with the specific objective of identifying more promising interventions to address the current inequities in access to the screening programme.
CONCLUSIONS
Neither a telephone call from a nurse nor a letter from a celebrity to encourage attendance for cervical screening were effective or cost-effective in women with a prolonged history of non-participation in the screening programme. A letter from the local cervical screening programme commissioner resulted in a small, non-significant increase in uptake. The low cost and ease of implementation of this intervention supports further research into its use in routine practice.
